The National Central Cancer Registry (NCCR) called for data in 2012 from all population-based cancer registries in China, and the datasets were used to update the annual estimation for new cancer cases and deaths in China after data evaluation and analysis.

There were 261 cancer registries, located in 32 provinces, autonomous regions, or municipalities, submitted cancer data in 2012. All data were checked and evaluated according to the criteria of data quality from NCCR, and 193 registries' data were qualified and accepted for this updated cancer statistics in China in 2012. Cancer registries collected information on new cancer cases from hospitals, community health centers, medical insurance agents, and the Vital Statistics System (for cases only identified by death certification). Registries obtained information on cancer deaths from the death surveillance system, which collects death information from hospitals and the Civil Administration Bureau with available cremation records. Population information was collected from local statistical bureau or household register department in local public security bureau. Proportion of morphological verification (MV%), percentage of cancer cases identified with death certification only (DCO%), mortality to incidence (M/I) ratio, percentage of uncertified cancer (UB%), and percentage of cancer with undefined or unknown primary site (secondary) (O&U%) were used to evaluate the completeness, validity, and reliability of cancer statistics. Pooled data were stratified by area (urban/rural), sex, age group, and cancer site. Cancer incident cases and deaths were estimated using age-specific rates, which were stratified by area (urban/rural), sex (male/female), and age (grouped by 0, 1--4, 5--9,..., 80--84, 85-year old and above). The Chinese population census in 2000 and the Segi's population were used for age-standardized rates (ASR) of incidence/mortality. The national incidences and mortalities were estimated using stratified rates and modelled national population in 2012.

All 193 cancer registries (74 urban and 119 rural registries) covered a total of 198,060,406 population (100,450,109 in urban areas and 97,610,297 in rural areas). The overall indicators MV%, DCO%, and M/I ratio were 69.13%, 2.38%, and 0.62, respectively. They were 70.63%, 2.63%, and 0.59 in urban registries, compared to 67.31%, 2.09%, and 0.65 in rural registries. The estimates of new cases and deaths were 3,586,200 and 2,186,600 in 2012, respectively.

The crude cancer incidence in China was 264.85/100,000 (289.30/100,000 in males and 239.15/100,000 in females), and age-standardized rates of incidence by the Chinese standard population (ASRIC) and by the world standard population (ASRIW) were 191.89/100,000 and 187.83/100,000 with a cumulative rate (for the whole population of 0--74 years old) of 21.82%. The crude incidence and ASRIC were 277.17/100,000 and 195.56/100,000 in urban areas and were 251.20/100,000 and 187.10/100,000 in rural areas. Cancer incidence was relatively low before 40 years old, after then increased dramatically, and finally peaked after 80 years old and slightly decreased after 85 years old. The pattern was similar between urban and rural areas (Table [1](#Tab1){ref-type="table"}).Table 1Cancer incidence in China in 2012(This table has been published previously and is reproduced with permission from the *Chinese Journal of Cancer Research*, see Ref. \[[@CR3]\])AreasSexNew cases (×10^3^)Crude incidence (1/10^5^)ASRIC (1/10^5^)ASRIW (1/10^5^)Cumulative rate (%)^a^All areasBoth3586.2264.85191.89187.8321.82Male2007.6289.30216.17214.3325.39Female1578.6239.15170.08163.8118.32Urban areasBoth1973.0277.17195.56190.8821.91Male1062.0292.31212.68210.6324.71Female911.0261.39181.30174.0019.28Rural areasBoth1613.2251.20187.10183.9121.67Male945.6286.00220.03218.4226.14Female667.6214.28156.14151.3517.14*ASRIC* age-standardized rate of incidence by the China population in 2000, *ASRIW* age-standardized rate of incidence by the Segi's population^a^ The cumulative rate of the whole population of 0--74 years old

The crude cancer mortality in China was 161.49/100,000 (198.99/100,000 in males and 122.06/100,000 in females), age-standardized rates of mortality by the Chinese standard population (ASRMC) and by the world standard population (ASRMW) were 112.34/100,000 and 111.25/100,000, and the cumulative mortality (for the whole population of 0--74 years old) was 12.61%. The crude mortality and ASRMC were 159.00/100,000 and 107.23/100,000 in urban areas and were 164.24/100,000 and 118.22/100,000 in rural areas. The cancer mortality was relatively low before 45 years old and then dramatically increased, reaching the peak after 85 years old. The mortality in rural areas was highest in the age group of 80--84 years old. The age-specific mortality in males was lower in urban areas than in rural areas in most of age groups before 80 years old (Table [2](#Tab2){ref-type="table"}).Table 2Cancer mortality in China in 2012(This table has been published previously and is reproduced with permission from the *Chinese Journal of Cancer Research*, see Ref. \[[@CR3]\])AreasSexDeaths (×10^3^)Crude mortality (1/10^5^)ASRMC (1/10^5^)ASRMW (1/10^5^)Cumulative rate (%)^a^All areasBoth2186.6161.49112.34111.2512.61Male1380.9198.99146.51145.5716.57Female805.7122.0680.0078.898.66Urban areasBoth1131.8159.00107.23106.1311.70Male706.2194.37138.60137.7415.30Female425.7122.1477.7476.558.18Rural areasBoth1054.8164.24118.22117.0613.63Male674.7204.06155.46154.2817.99Female380.1121.9882.6481.609.21*ASRMC* age-standardized rate of mortality by the China population in 2000, *ASRMW* age-standardized rate of mortality by the Segi's population^a^ The cumulative rate of the whole population of 0--74 years old

Lung cancer was the most common cancer in all areas, followed by gastric, liver, colorectal, and esophageal cancers with estimated new cases of 704,800, 423,500, 366,100, 331,300, and 286,700, respectively. Lung cancer was the most frequently diagnosed cancers in males, followed by gastric, liver, esophageal, and colorectal cancers; breast cancer was the most common cancer in females, followed by lung, colorectal, gastric, and cervical cancers (Table [3](#Tab3){ref-type="table"}; Figs. [1](#Fig1){ref-type="fig"}, [2](#Fig2){ref-type="fig"}). The ten most common cancers accounted for approximately 77.4% of all cancer cases in urban and rural areas. In urban areas, lung cancer was the most frequently diagnosed cancer, followed by colorectal, gastric, female breast, and liver cancers. Lung cancer had been becoming the most frequently diagnosed cancer (326,600 new cases with an incidence of 50.86/100,000), followed by gastric, esophageal, liver, and colorectal cancers.Table 3Top ten cancer incidences in China in 2012(This table is modified from a previous publication with permission, see Ref. \[[@CR3]\])![](40880_2016_137_Tab3_HTML.gif){#d30e782}*CNS* central nervous systemFig. 1Cancer incidence and mortality in urban and rural areas for males in China in 2012 (1/100,000). *CNS* central nervous systemFig. 2Cancer incidence and mortality in urban and rural areas for females in China in 2012 (1/100,000). *CNS* central nervous system

Lung cancer was the first leading cause of cancer death in China, followed by liver, gastric, esophageal, and colorectal cancers with estimated deaths of 569,400, 321,200, 298,500, 210,900, and 159,300, respectively. In males, lung cancer was the leading cause of cancer death, followed by liver, gastric, esophageal, and colorectal cancers; whereas in females, lung cancer was still the leading cause of cancer death, followed by gastric, liver, colorectal, and esophageal cancers (Table [4](#Tab4){ref-type="table"}; Figs. [1](#Fig1){ref-type="fig"}, [2](#Fig2){ref-type="fig"}). The top ten leading causes of cancer death accounted for approximately 84.5% of all cancer deaths. The cancer patterns showed difference between urban and rural areas and between males and females. The leading causes of cancer death in rural areas were lung, liver, gastric, esophageal, and colorectal cancers, whereas the leading causes of cancer death in urban areas was lung, liver, gastric, colorectal, and esophageal cancers.Table 4Top ten cancer mortalities in China in 2012(This table is modified from a previous publication with permission, see Ref. \[[@CR3]\])![](40880_2016_137_Tab4_HTML.gif){#d30e847}*CNS* central nervous system

Compared with the figures in 2011 \[[@CR1]\] and 2010 \[[@CR2]\], cancer burden kept increasing, mostly because of the population increase and aging. Timely report of cancer registry provides basic information for policymakers, researchers, and clinicians. With the registry data getting more accurate, it plays more important role in cancer control in China.
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